- New alliance will crack down on adulterated products touting dietary supplement claims
- FDA approves Merck's Gardasil for prevention of anal cancer
- FDA approves Novartis drug for high blood pressure treatment
- Adherence among chronic disease patients can lead to big savings
- Pfizer forms licensing agreement with Seattle Genetics
NEW YORK — The Food and Drug Administration has approved a gel formulation of a foot fungus drug made by Merz Pharmaceuticals, according to published reports.
According to reports, the FDA approved a gel formulation of Merz's Naftin (naftifine), used to treat athlete's foot, known medically as tinea pedis.
A cream version of the drug is already approved, and the latest approval was based on two clinical trials of more than 1,700 patients, according to reports.